TY  - JOUR

T1  - Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

JO  - Health technology assessment (Winchester, England)

PY  - 2007/03/01

AU  - Tappenden P

AU  - Jones R

AU  - Paisley S

AU  - Carroll C

ED  - 

VL  - 11

IS  - 12

Y2  - 2024/12/22

ER  -